NexGard Combo is a systemic isoxazoline-based endectocide designed specifically for cats which contains esafoxolaner, eprinomectin and praziquantel.
The new product provides one month’s protection against fleas and five week's protection against the most common tick on cats, Ixodes ricinus. It also treats the roundworms, Toxocara cati and Toxascaris leonina, hookworms, tapeworms and ear mites, against the last of which Nexgard Combo provides 97.2 to 99.9% efficacy following one treatment1.
NexGard Combo can be used in kittens from eight weeks of age and 0.8 kg in weight, making it suitable for most kittens at first vaccination. It is available in two pack sizes: small, for kittens weighing 0.8 - 2.5kg and large, for adult cats weighing 2.5 - 7.5kg. For cats weighing 7.5kg or over, an appropriate combination of applicators should be used.
Jackie Sterratt, senior brand manager at Boehringer Ingelheim, said: “We’re excited to add to the successful NexGard range and to help vets treat more cats. We know only one in two cats is treated for fleas2 and cats are only wormed on average three times per year3 despite all cats being at risk of fleas and most cats requiring monthly roundworming treatment2, 3, so there is a big opportunity to increase treatment rates and compliance. As the only product on the market to treat fleas, ticks, ear mites, roundworms and tapeworms, NexGard Combo offers a simple solution for cats at risk of multiple parasites."
To support the launch Boehringer has produced a marketing package which includes a kitten support pack, client leaflets, dispensing envelope and parasite risk checker.
For further information, contact your local Boehringer Ingelheim territory manager or phone 01344 746957 (UK) or 01 291 3985 (Ireland).
References
Animalcare Marketing Manager, James Beaumont said: “Practice life is busier than ever and we know that practice teams are working very hard. It’s important that they are well-fuelled, so we aim to nourish their bodies and minds with our new Daxocox ‘Bitesize Lunch and Learns’. We’re simply asking practices to tell us their lunchtime desire and we’ll make sure that it’s delivered direct to their door.
"Then, in less time than it takes for them to demolish their feast, we’ll explain how breakthrough pain could be haunting their canine OA patients and, more importantly, how our new weekly NSAID, Daxocox, can help."
Practices can register for a lunch and learn and submit their lunch order by registering at www.daxocox.co.uk/lunch_learn or contacting Animalcare on 01904 487687.
The publishers say that with a global donkey population estimated at around 46 million, it’s imperative for the veterinary profession to stay well-informed about the unique biology and disease susceptibility of this species.
The virtual collection addresses the previous shortfall of pathophysiological information, with articles on pharmacology, diagnostics, disease prevalence and management practices relating to donkeys as working, companion and production animals.
Preventative healthcare is addressed with a study of a companion population of donkeys in the UK and clinicians are encouraged to focus on client education, promotion of vaccination, regular dental care, strategic parasite control programmes and weight management.
Several papers address decision-making around treatment options, emphasising the need for a good understanding of the pharmacology of the available therapeutic agents in relation to donkeys and the pathophysiology of the diseases, as well as the value of pain assessment and control.
Another important aspect of disease detection and management is the availability of accurate diagnostics. Several papers address aspects of diagnostic testing, with emphasis on the caution that must be taken when extrapolating from horses because of the minimal data relating specifically to donkeys.
Donkeys are often described as silent carriers of, or as being more resistant to, infectious agents. Two articles demonstrate that they can in fact develop severe clinical signs when exposed to certain known equine pathogens, raising the importance of surveillance, accurate diagnosis, outbreak management, disease control and clear communication and education.
Less common conditions in donkeys as well as awareness of zoonotic risk are addressed within the collection, emphasising the value of owner-driven reporting as part of a disease surveillance and control programme to inform decision making on relevant interventions.
Professor Celia Marr, Editor of the EVJ, said: “This impressive collection shines a spotlight on the important advances that have been made to donkey medicine and welfare and helps us to identify the research gaps yet to be filled
“By sharing this work, we aim to improve disease prevention and enhance the welfare of donkeys around the world as well as highlight the continued importance of owner education and improve the public perception of this enduring species.”
The virtual issue can be found here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.donkey-medicine-welfare.vi
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
At the start of the hearing the RCVS applied for it to take place in the absence of Mr Dobson, who had failed to respond when informed about the hearing. The application was granted by the DC on the basis that Mr Dobson, by refusing to respond to communications from the College – including by letter, telephone and email – had voluntarily waived his right to attend.
There were three sets of charges against Mr Dobson. The first charge was in June 2018, while he was not on the Register of Veterinary Surgeons, Mr Dobson had carried out an equine pre-purchase examination (PPE) and used the postnominals MRCVS to sign the associated PPE certificate and covering letter.
The Committee found this charge proven after it was presented with evidence of the certificate and covering letter alongside the fact that Mr Dobson had been removed from the Register on 1 June 2018 for non-payment of the annual renewal fee needed to remain on the RCVS Register. He was only restored to the Register upon paying his outstanding fee in late November 2018.
The second charge was that Mr Dobson did not have any professional indemnity insurance (or PII) or other equivalent arrangements in between June 2018 and August 2020. He also failed to provide adequate details of his PII when requested by the RCVS.
The Committee was presented with evidence that Mr Dobson had failed to confirm that he had PII arrangements or other equivalent arrangements in place prior to August 2020 and that he had failed to respond to numerous requests for evidence from the College. On this basis the Committee found the charges proven.
The third and final charge was that Mr Dobson had failed to respond to numerous requests from the RCVS, including: failing to provide written comments on concerns relating to the equine PPE; failing to provide written comments on the concern that he had carried out the PPE and used the postnominals MRCVS while not on the Register; failing to provide details of his continuing professional development (CPD) for the previous three years; and failing to provide copies of his Day Book and/or Controlled Drugs Register. All elements of this charge were found proven when the Committee was presented with evidence of numerous attempts to contact him that went unacknowledged and unanswered.
Regarding the first charge, the Committee recognised that Mr Dobson had not intentionally allowed his registration with the College to expire and that it was down to administrative error. However, it also considered that he had not responded to or taken action upon receiving numerous reminders to pay his fees. It considered that Mr Dobson had therefore acted recklessly in not only allowing his registration to expire but in continuing to practise veterinary surgery while not registered, a criminal act in contravention of the Veterinary Surgeons Act. The Committee therefore found that the first charge amounted to serious professional misconduct.
The Committee also found that the remaining charges constituted serious professional misconduct.
Cerys Jones, chairing the Committee and speaking on its behalf said: "The respondent demonstrated a pattern of behaviour in not responding, which was sustained and persistent. He asked for extensions of time but did not make good on his assurances that he would provide information. Due to the length of time during which the respondent failed to comply with the requests, as well as the proliferation of issues in respect of which he did not comply, the Committee was of the view that he demonstrated a wilful disregard of the role of the RCVS and the regulatory processes. This was particularly serious in light of the reliance which the RCVS places upon its members to cooperate with providing it with information relating to their professional practice which is relevant to the RCVS’s regulation of the profession.
"There was no harm caused to animals or the public, and the Committee acknowledged that practice circumstances have been made more difficult in general by the Covid-19 pandemic. However… the respondent’s failures to comply were serious and undermined the functions of the RCVS. The Committee was satisfied that the respondent’s failures fell so far below what was expected as to amount to serious professional misconduct."
Having found that all the charges amounted to serious professional misconduct the Committee then considered the most appropriate sanction for Mr Dobson. In terms of aggravating factors, the Committee considered Mr Dobson’s recklessness in failing to renew his registration and practising while it was lapsed, his pattern of not responding to the RCVS, the fact that financial gain was obtained as a result of misconduct, a wilful disregard to the RCVS and regulation, and limited evidence of insight. In mitigation the Committee considered Mr Dobson’s previous good character, a long and otherwise unblemished career, the fact that no animals were harmed and increased demands on time and processes due to Covid-19.
However, taking all of the information into account, the Committee decided that removal from the Register was the appropriate and proportionate sanction due to the sustained and prolonged nature of the misconduct.
Cerys Jones said: “The respondent demonstrated a wilful disregard of the role of the RCVS and the regulatory processes by way of his disgraceful conduct. In addition, his lack of engagement with the hearing process indicates to the Committee that he is not engaging with his regulator and, along with the limited insight and lack of remediation with respect to the disgraceful conduct, this demonstrates a lack of insight into the seriousness of his actions or their consequences.”
Three bursaries are available - two in ruminant and one in companion animal research, each worth up to £4,000.
Annabelle Mohring, Veterinary Advisor at MSD Animal Health said: "We appreciate that the last 18 months have been challenging for many veterinary surgeons and adding new research to this may not be considered a priority. But with the pace of change rapidly increasing, improving business skills and scientific knowledge will become more important than ever for the profession.
"Research forms the foundation of the industry and being awarded a bursary has proved to be a career-changing experience for some participants. We're now welcoming applications as part of our investment in the veterinary community."
Each project should be completed within one to two years and the veterinary surgeon proposals will be judged by objective third party university academics to ensure independent assessment.
The deadline for the MSD Animal Health Veterinary Surgeon Research Bursaries is 30th November 2021.
For further information, visit: www.msdahresearchbursary.co.uk.
Photo: Hattie Barnes who was awarded the 2020 Veterinary Surgeon Bursary in the companion animal sector. She was awarded £4,000 for her analytical, cadaver-based study to investigate different draping protocols in elective orthopaedic surgery. Hattie is currently undertaking a 3-year residency in Equine Surgery at the University of Liverpool.
Specifically, they're using them as a sheep race of sorts, for patient restraint during fluoroscopic examinations.
Eastcott says the transparent barrier helps to keep patients as close as possible to the practice’s mobile image intensifier, while also limiting any sudden movement. This significantly improves the quality of images taken and reduces the amount of time taken per examination.
Nicholas Taylor, referral radiographer at Eastcott came up with the idea. He said: “Unlike us humans, animals don’t understand the need to remain still and the process of getting these images was becoming quite challenging and time-consuming. Often the length of the process would make the animal anxious and we would inevitably be going in circles.
"The idea came about when we were discussing how we could replicate the x-ray process in the human world, where machines are often very close to the patient’s body.
"We had a few spare desk barriers in the hospital and decided to give it go. We were so pleased at how easy it made the entire process, reducing the amount of time per exam, improving the quality of pictures and ultimately putting the patient at ease since they can see what is going on around them.”
Instead of the traditional format, where one expert, perhaps two, come and lecture on a subject, IVC has gathered together experts from different disciplines to give their differing perspectives on a subject, each talking for 30 minutes.
For example, you'll be able to hear about BOAS surgery from the perspective of a Specialist in Small Animal Internal Medicine, an anaesthetist, a Specialist in Small Animal Surgery and a Specialist Surgical Nurse.
Collapse will be covered by a neurologist, a cardiologist and an ECC specialist.
IVC says the aim is to make the sessions as concise and to-the-point, but as practical as possible, and you'll be able to come and meet the speakers on the stand afterwards.
Richard Artingstall (MBA, MA, Vet MB, CertSAS, MRCVS, RCVS Advanced Practitioner in Small Animal Surgery) from Vale Referrals and the IVC Evidensia Referrals Strategy Group, said: "Working our Referrals and Equine streams like this gives delegates the opportunity to gain a real insight, from different disciplines, into how our specialists work up a case.
"The lectures will offer practical, discipline-based guidance, looking at clinical presentations and problems from different discipline perspectives. Our hope is that this will help delegates in decision making and planning case management plans for these more tricky case presentations in practice. I think it will be incredibly useful for them and I can’t wait to be there."
More information: https://london.vetshow.com/ivc-clinical-theatre
Apovomin is effective after a single injection, with results in two to fifteen minutes.
Apovomin has the active substance apomorphine hydrochloride hemihydrate 3 mg (equivalent to apomorphine 2.56 mg). It is being marketed in 5 ml vials. It has a three-year shelf life and lasts for up to 28 days once broached.
Dechra Brand Manager Claire Morgan said: “Unfortunately there are many everyday substances that are toxic to dogs once ingested and time is of the essence when dogs have swallowed something that is poisonous to them.
“It is vital that veterinary professionals have access to a safe and effective treatment like Apovomin that they know they can rely on when dealing with cases like this.
“Apovomin offers a cost effective and successful treatment for accidental poisoning that will be an important tool for veterinary professionals in day-to-day practice.”
For more information visit www.dechra.co.uk.
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
In the study titled 'Staphylococcal bacterial contamination of portable electronic devices in a large veterinary hospital1', samples were taken from the screen and any button of PEDs (such as mobile phones and tablets) of staff working directly with feline and canine patients. Hospital staff were asked to complete a questionnaire to ascertain the frequency of PED use and the frequency and method of PED cleaning.
The aim of the study was to determine the prevalence of Staphylococcal contamination of PEDs in a veterinary hospital, and to identify the source and determine the pathogenesis of any cultured strains.
Positive cultures were tested for resistance to oxacillin and vancomycin using a Kirby-Bauer disc diffusion test and then by using a broth microdilution test to EUCAST guidelines and breakpoints. PCR was used to specifically genotype the isolated staphylococci.
Georgia Vinall, corresponding author for the paper, said: “Useable swab samples were taken from 47 devices. Staphylococcus spp. were cultured from 68% of PEDs with a median of 10 colonies grown per device. Vancomycin-resistant Staphylococcus spp. were found on 36% of devices, whilst oxacillin-resistant Staphylococcus spp. were cultured from 2% of devices. DNA sequencing identified three Staphylococcus species; S. capitis, S. epidermidis and S. hominis which are most likely associated with humans as either sources or transmission vectors."
“The results of the survey indicate that 96% of staff had a PED which they used in the hospital environment, of which 85% use their device every day. Despite the high usage of PEDS in the hospital environment, only 6% of staff cleaned their device daily, with 33% of staff cleaning their PED less than weekly. Furthermore, only 54% of staff cleaned their device with a disinfectant."
Nicola Di Girolamo, Editor of JSAP said: "This study demonstrates that PEDs may become contaminated with potentially pathogenic microorganisms. Although this specific study did not focus on transmission of these microorganisms, and therefore it is unclear what are the clinical implications of this finding, it seems prudent to develop appropriate protocols for cleaning of PEDs in veterinary hospitals."
The full article can be found in the April issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13289.
Reference
Alex is applying the data science he uses in his day job to help local vets at the Olive Ridley Project care for the ancient reptiles.
Six of the seven species of sea turtles are endangered due to human behaviour, many of them killed by poachers for their shells, eggs and meat.
They're also affected by the increasing volume of plastic waste in the sea.
Alex, who normally spends his time leading a team of business intelligence engineers and analysts who provide insights in finance, HR and clinical event reporting, is setting the charity up with practice management software to help it capture clinical records and track the sea turtles.
Alex said: "We’ll be setting up the software, making sure the vets can operate it and then adding all their existing data to it. We’re giving them a powerful tool to capture clinical records and manage turtles over a long period of time.”
“These valuable creatures are hugely important to marine ecosystems and have travelled our seas for the last 100 million years, so I’m delighted to be able to play a part in their conservation.”
For more information on the Olive Ridley Project, visit https://oliveridleyproject.org.
The company says that by encouraging socialisation, natural behaviour and good health practices, the campaign will help puppy owners get their journey off to a good start and, with their vet, raise a dog that is healthy and family friendly.
The initiative comprises a range of practice materials, including health advice, training and behaviour tips, and a new owner video covering the essentials of puppy ownership.
The materials include digital content to use in email campaigns and on practice websites and social media channels.
Further support on how to optimise social media channels is also available to practices through PetNatter – Boehringer's free veterinary resource designed to help practices make the most of the opportunities social media provides.
Evelyn Murphy, senior brand manager for NexGard Spectra, said: “The ‘Relax, it’s a Puppy Thing’ initiative is a breath of fresh air and will provide puppy owners with just what they need to help them nurture a puppy through its formative life-stage, while easily and effectively supporting practices in communicating with owners on puppy health and welfare.”
For further information, contact your Boehringer Ingelheim territory manager.
The course counts for four hours CPD, split into six short sessions which can be completed in your own time.
Presented by Dr Dan Cripwell BSc (Hons) BVSc CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox, the sessions consist of:
There is a quiz at the end of each module, following which, you can download a CPD certificate.
Suzy Ramsay, head of sales and marketing at Jurox (UK) Limited, said: “We are committed to developing unique and world class anaesthesia and analgesic products and practices within the animal health industry through the provision of up-to-date technical support and education. Our new Jurox Anaesthesia Academy CPD platform will enable veterinary professionals to adopt an evidence-based approach to their anaesthetic product choice and, in turn, help achieve the best possible anaesthetic outcomes for their patients.”
For access to the Jurox Anaesthesia Academy CPD platform, visit https://cpd.jurox.co.uk.
For further information, contact your local Jurox account manager, phone 0800 500 3171 or email customerservice@jurox.co.uk.
The service is being led by Isuru Gajanayake, a board-certified specialist in veterinary nutrition. He said: “Since launching our clinical nutrition service last year, we have seen a number of cases in which patients have been either dehydrated or malnourished, sometimes both.
“Working alongside our other services in a truly multidisciplinary approach, we have been able to offer suitable treatment to support a significant number of dogs and cats.
“With the launch of the parenteral nutrition service, we can now expand this offering and, in doing so, become one of only a very few referral centres across the UK to provide this as a specialist service.
“Patients who are given parenteral nutrition will be hospitalised in our advanced intensive care unit to ensure they can be monitored closely by our specialist emergency and critical care (ECC) team, who provide exceptional expertise in critical care and treatment for every patient when they need it most.
Isuru added that the addition of the clinical nutrition and parenteral nutrition services at Willows ensures that there is a much greater emphasis on nutrition and hydration for all patients at the centre, whatever their underlying illness.
For more information, visit www.willows.uk.net or search for Willows Veterinary Centre and Referral Service on Facebook.
The brainchild of Sonya Miles CertAVP(ZM), CertAqV, MRCVS, Just Exotic (www.justexotics.co.uk) offers a range of training webinars, fact sheets, care sheets and ‘how to’ videos developed for veterinary surgeons, nurses and students. The webinars cost between £15 and £55 (depending on the length), and include presentations by Sonya herself, Eliabetta Mancinelli, Agata Witkowska, Louise Ash, Sarah Pellett and others.
Sonya said: “We’ve developed our content to be convenient and affordable. Some of it may also be helpful for clients.
"More content will be added on a regular basis, and please, if there is something you specifically want covered, drop us a line to info@justexotics.co.uk and will we do our best to make sure it becomes available.”
The specialist-led lectures will start on 5th May and run until October 2021, with a session every couple of weeks, alternating between vets and nurses.
RCVS-recognised specialist in ECC, Tobias Grave, and Racheal Marshall RVN, head of clinical nursing at Vets Now, are among the speakers who will be covering topics such as damage control resuscitation, traumatic brain injury and neurotoxins. You can view the full programme here.
Dan Lewis, ECC specialist at Vets Now, who devised this year’s veterinary CPD programme, said: “Because emergencies don’t only happen out of hours we’re committed to working with general practitioners to deliver the best possible care to pets at the time they need it most. With that in mind, we are also committed to bringing relevant and pioneering CPD and training to veterinary clinicians and vet nurses.
“As emergency and critical care experts, we appreciate the value of flexibility and are always looking to adapt our services. In 2021, with social distancing still expected to be the norm, we’re offering two CPD streams, available live and on-demand.
“We delivered a successful interactive learning experience for virtual delegates through our ECC Congress at the end of last year, so we have a strong foundation from which to build on innovative and expert virtual CPD, and we’ll aim to leave delegates feeling well-informed and assured.
“We will obviously miss seeing everyone in person but gathering together online like this is beneficial as we can reach more vets and vet nurses with valuable CPD. Importantly, the format can fit around busy schedules, with all content available as videos after the events have taken place.”
Dan added: “Delegates from our ECC Congress commented on some added benefits of the virtual format including things like less environmental impact and waste through less travelling, and more flexibility due to being able to look back on the content after the event. Delegates also felt it was easier to ask questions of the speakers without feeling intimidated.”
The event series is priced at £72 for the vet stream (working out at £12 per session) and £60 for the vet nurse stream (£10 per session). You can also attend both for £110 (working out at £9.16 per session).
You can book your place at www.vets-now.com/bitesize.
The company says the reason for the change is so that it can dedicate additional resources to the business.
Samantha Williamson, UK Country Manager at Animalcare, said: "Through our identichip microchips and our identibase pet database, we provide one of the UK’s longest-established pet microchipping services and are helping to reunite owners with their lost pets every single day.
"The pet reunification sector is evolving rapidly thanks to technological advances. We believe that the creation of identicare will facilitate the concentration of resources and expert knowledge needed to fuel the growth in our identichip business and continued enhancements to the identibase pet database. identicare will share the same passion and values as Animalcare and there will be no outward change for our customers.
“We look forward to continuing to deliver our ambition of delivering the highest quality pet reunification service under the identicare banner.”
The new company is part of the Animalcare Group.
The new leaflet, ‘Separation anxiety as a result of the pandemic. What can you do?’, was written in collaboration with clinical animal behaviourist, Rosie Bescoby, and is aimed at dog owners whose pets are struggling to adjust to the ‘new normal’.
It includes an overview of separation anxiety, including the signs to look out for and how to tackle it, together with training tips to help adult dogs and preventative advice for puppies.
The leaflet also includes advice on the dog fear ladder, which demonstrates the different levels of fear a dog may exhibit resulting in more extreme reactions being displayed, and information on the Adaptil range of products which help support dogs throughout their lives.
The leaflet is available as both a printed and online version to enable vet practices to distribute it to their clients in a format of their choice. It is supported by a social media toolkit for vet practices consisting of posts, graphics and a video.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: “Lockdowns have been a positive experience for many of our dogs, as they are social animals and love being with their owners.
“However, with the 2021 PFMA annual pet population report confirming that 3.2 million households in the UK have acquired a pet since the start of the pandemic, some pet owners have never left their dogs home alone, so it’s going to be a totally new experience which some pets may struggle with.
"Our new separation anxiety leaflet will help support both pets and owners as they adjust to the new normal.”
For further information, contact your local Ceva Animal Health account manager or email cevauk@ceva.com.
60 vets took part in the survey. 80% believed they had seen an increase in behavioural problems since lockdown. Over 60% reported an increase in the incidence of obesity and diarrhoea. Nearly 50% had seen an increase in urinary tract disorders and haemorrhagic gastroenteritis.
When asked which conditions had been harder to manage clinically since the start of the pandemic, the top seven conditions were:
Medicine specialist, Dr Stefanie Mitze (pictured right) said: “We conducted the survey to help us understand changes in disease incidence and the clinical challenges faced by our colleagues in first opinion practice over the last year.
"The fact that the incidence of disorders which can have a stress-related component, including behavioural problems, diarrhoea and urinary tract disease, were reported to have increased by a high proportion of respondents indicates that many pets may be experiencing heightened stress during the pandemic.”
Stefanie is now creating a series of free bitesize CPD videos to help manage these more challenging cases. She said: “We recognise the past year has been challenging, especially with complex staffing issues, reduced vet visits and restricted face-to-face communication with clients. For complex, chronic medical conditions, especially those which require frequent follow up, we wanted to support colleagues in providing the best care possible in the current circumstances. We hope these CPD sessions will provide practical tips to help deliver just that.
The CPD sessions are available at: https://www.hamiltonspecialists.vet
Prevexxion RN is composed of a serotype-1 construct vaccine which Boehringer says offers a unique balance between safety and efficacy against the most virulent types of Marek’s disease virus strains.
Prevexxion RN+HVT+IBD is a solution combining Prevexxion RN and Vaxxitek HVT+IBD in one ampoule. It is designed to meet the needs of customers in long-life bird segments with protection from the hatchery.
Prevexxion RN vaccines are available in ampoules of 1000, 2000, and 4000 doses, frozen in liquid nitrogen.
Jerôme Baudon, Head of Poultry at Boehringer Ingelheim, said: “Our Prevexxion RN range provides value through innovation to Marek sensitive poultry producers looking for continuous live production productivity improvement and effective protection. Field and lab experiments conducted worldwide demonstrated its safety, efficacy and its strong, early, and long-lasting protection through the lifespan of the birds and against very virulent Marek’s disease challenge.
Prevexxion RN is the new golden standard for Marek's disease vaccination programs2”.
For more information, contact your Boehringer Ingelheim representative.
Zoetis says Librela (bedinvetmab) and Solensia (frunevetmab) work differently from NSAIDs, the current standard of care, by specifically targeting NGF, a key player in OA pain1.
As monoclonal antibodies, they are eliminated by the body in the same way as naturally occurring proteins, with minimal involvement of the liver or the kidney2.
John Innes, BVSc, PhD, MRCVS (Small Animal Orthopaedics), Chief Veterinary Officer and Referrals Director at CVS said: “The potential for anti-NGF therapy to control OA pain is an exciting new development, representing a new therapeutic class, an innovative tool for clinicians working to alleviate OA pain, and a new medicinal innovation.
"NGF is one of the key factors mediating pain, inducing the release of both proinflammatory mediators and more NGF contributing to a cycle of pain and inflammation. I welcome this innovative tool for clinicians working to alleviate OA pain.”
In a field study (three-month placebo-controlled, followed by six months continuation therapy), Librela administered as monthly injections demonstrated a reduction in osteoarthritis pain as compared to placebo-controlled dogs.
According to the company, the pain reduction was maintained throughout the six-month continuation study, demonstrating sustained efficacy of Librela for at least nine months.
Solensia administered as monthly injections during two multi-center, randomized, placebo-controlled, double-blind field studies that enrolled a total of 360 cats demonstrated that in both studies, ≥76% Solensia-treated cats were considered a treatment success by the owners and veterinary-assessed joint pain scores decreased by >50% in these cats by study end2.
Mike McFarland, DVM, Executive Vice President and Chief Medical Officer at Zoetis said: “Globally osteoarthritis (OA) pain impacts nearly 40% of cats and dogs suffering from the condition2,4.
"OA pain is under-diagnosed as pet owners often think signs of pain are related to ‘normal’ signs of ageing.
"The most common medications used to treat OA pain today are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)1, While effective, current treatment choices can have limitations. Additionally, middle aged to senior pets may have other diseases that require multiple medications. Not all pets respond to NSAID therapy and some will not tolerate NSAIDs. This can lead to under-treatment today of OA pain.
“With Solensia for cats and Librela for dogs, veterinarians will now have access to once-monthly breakthrough solutions for the management of pain associated with osteoarthritis – offering a new alternative to veterinarians to improve the quality of life for pets and their owners.”
Librela (bedinvetmab) is launched today in the European Union, United Kingdom and Switzerland. Solensia (frunevetmab) will launch in Europe, United Kingdom and Switzerland in May.
Animalcare hopes that its ‘Make Senior Easier’ campaign will raise awareness of conditions that can go unnoticed or get dismissed by owners as a normal part of ageing, such as hyperthyroidism.
As part of the campaign, practices can request a free resource pack which includes:
Kirsty Cavill RVN said: ''In my role as a RVN and canine rehabilitation therapist, I often come across senior pets with underlying conditions which are adversely affecting their health but could be managed successfully through a multimodal approach and structured treatment plan.
"By adopting a proactive approach to senior pet care and by helping owners to understand how to best support their pets through this life stage, we will strengthen the bonds with our clients, to ensure the highest standard of care is afforded to all senior patients.''
James Beaumont, Brand Manager at Animalcare, added: "As life expectancy increases and numbers of senior pets continue to grow, veterinary care tailored to the needs of these animals has never been more relevant and it is also a huge business opportunity for practices. To help them capitalise on this opportunity, we have created our Make Senior Easier campaign and hope that the resources we have created will improve owner awareness and give practices the tools they need to achieve the best clinical outcomes for older pets and their owners.”
To request your free resource pack, visit: www.animalcare.co.uk/makesenioreasier.
For more information, contact your Animalcare Territory Manager or ring 01904 487687.
Elanco says Baycox Iron offers a time-saving flexible dosing treatment which complements the company’s existing piglet gut health portfolio.
Louise Radford, marketing manager at Elanco, said: "By treating piglets at two or three days old, it’s possible to allow enough exposure to the coccidiosis parasite to enable them to develop natural immunity, while preventing any damage to the gut caused by subclinical and clinical coccidiosis which leads to poor growth and low weaning weights.
"By combining treatments, it's possible to limit the number of times they are handled, which in turn reduces stress and enhances growth”.
Elanco also makes the Coliprotec vaccine against post weaning diarrhoea (PWD).
Louise added: “As farmers and vets prepare for the removal of zinc oxide as a treatment option next year, focusing on gut health throughout all stages of development has never been more crucial.
For more information, contact your Elanco pig team specialist or visit https://www.myelanco.co.uk/cpd/swine/hub.